Sarah’s practice focuses on advising private and public companies on an array of executive compensation, employee benefits and corporate governance matters throughout the corporate lifecycle, including establishing equity and cash-based incentive programs; providing analysis of tax implications with respect to tender offers and other liquidity programs; negotiation of executive employment agreements, change in control plans and severance agreements; structuring of equity compensation terms and employee retention matters in M&A, including analysis of potential tax liabilities under Section 280G; and advising clients on executive compensation and equity plan disclosures in connection with IPOs and subsequent SEC filings.

Sarah’s recent experience includes advising:

• Capella Space on its $60 million growth equity financing.
• Coupa on its pending $8 billion sale to Thoma Bravo.
• TriNet Group, Inc. on its $109 million modified Dutch auction tender offer.
• AeroClean Technologies, Inc in connection with its all-stock merger with Molekule, Inc.
• TriNet on its acquisition of Clarus R+D Solutions.
• eBay on its acquisition of TCGplayer.
• Zymergen on its pending $300 million sale to Ginkgo Bioworks—the first-ever sale of a publicly-listed public benefit corporation.
• Google on numerous matters, including its acquisitions of Global Weather Corporation and Dysonics.
• TriNet on its acquisition of Zenefits and $316m modified Dutch auction tender offer.
• Zymergen on its $575m IPO and listing on Nasdaq as a public benefit corporation, and on its acquisition of Lodo Therapeutics.
• Agilent Technologies on numerous matters, including its acquisition of Resolution Bioscience.
• Rayner Surgical on its acquisition of OMIDRIA from Omeros in a transaction valued in excess of $1bn.
• Saint-Gobain on its $2.3bn acquisition of GCP Applied Materials.
• Coupa Software, Stanley Black & Decker, TriNet and Zymergen in connection with ongoing executive compensation, benefits and corporate governance advice.